Remove Anatomy Remove Heart Attack Remove Strokes
article thumbnail

AI Image Analysis App Receives FDA 510(k) Clearance

DAIC

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed tomography angiography (CCTA) scans to determine the presence, extent and severity of coronary plaques and luminal stenosis (narrowing of arteries). But with AI, we can change that.

Plaque 52
article thumbnail

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

DAIC

mg tablet), ananti-inflammatory atheroprotective cardiovascular treatment, to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease. mg on atherosclerotic plaque.

article thumbnail

Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter

DAIC

1 People suffering from PAD have not only impaired quality of life but also increased risk of heart attack or stroke. PAD affects more than eight million people aged 40 and older in the United States. 2 CLTI is the most advanced and serious form of PAD, impacting nearly 2 million patients in the U.S.

article thumbnail

Trial Results: Low-Dose Colchicine Helps Treat Cardiovascular Disease

DAIC

mg tablet), ananti-inflammatory atheroprotective cardiovascular treatment, to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease. mg on atherosclerotic plaque.

article thumbnail

Image Analysis Software for Cardiovascular Disease Assessment Gets 510(k) FDA Clearance

DAIC

tim.hodson Tue, 10/01/2024 - 10:50 PHOTO CAPTION: The Elucid PlaqueIQ user interface is a fully interactive visualization of the patient’s coronary anatomy, showing specific plaque type and amount across various views to inform physician assessment of risk and patient-specific treatment pathway.